GSK May 2023 38.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:14AM EST. Market open.
Loading interactive chart…
- Bloomberg
Deutsche Bank, UBS in Focus as Wall Street Sends Mixed Signals
(Bloomberg) -- As earnings season gathers pace, a slew of weak results and a hawkish European Central Bank risk spoiling the rally that spurred European equities to their best-ever start to a year. Most Read from BloombergAdani Rout Hits $68 Billion as Fight With Hindenburg IntensifiesAdani Tries to Calm Investors With 413-Page Hindenburg RebuttalWall Street Is Losing Out to Amateur Buyers in the Housing SlumpHistoric Crash for Memory Chips Threatens to Wipe Out EarningsRussia Can’t Replace the
- Investing.com
Unilever outperforms, edging higher after naming Hein Schumacher as new CEO
By Geoffrey Smith
- Zacks
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2023 Yahoo. All rights reserved.
